We are live on ! Find out more
AC

Armistice Capital Portfolio holdings

AUM $5.62B
1-Year Est. Return 36.06%
This Fund
S&P 500
This Quarter Est. Return
+15.6%
1 Year Est. Return
+36.06%
3 Year Est. Return
+44.14%
5 Year Est. Return
+38.37%
10 Year Est. Return
+188.88%
AUM
$8.4B
AUM Growth
+$1.66B
Cap. Flow
+$1.33B
Cap. Flow %
15.85%
Top 10 Hldgs %
61.33%
Holding
510
New
182
Increased
113
Reduced
52
Closed
146

Top Buys

Rank Stock Value
1
AGIO icon
Agios Pharmaceuticals
AGIO
+$79.7M
2
MDGL icon
Madrigal Pharmaceuticals
MDGL
+$74.4M
3
KVUE icon
Kenvue
KVUE
+$65.3M
4
ELF icon
e.l.f. Beauty
ELF
+$51.7M
5
GSK icon
GSK
GSK
+$46.6M

Top Sells

Rank Stock Value
1
TVTX icon
Travere Therapeutics
TVTX
+$96.3M
2
EXAS
Exact Sciences
EXAS
+$56.4M
3
PTCT icon
PTC Therapeutics
PTCT
+$34.5M
4
REGN icon
Regeneron Pharmaceuticals
REGN
+$28M
5
MDB icon
MongoDB
MDB
+$23M

Sector Composition

Rank Sector Weight
1 Healthcare 32.56%
2 Technology 5.44%
3 Consumer Discretionary 5.13%
4 Consumer Staples 2.69%
5 Communication Services 1.68%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
XOM icon
151
ExxonMobil
XOM
$628B
$2.74M 0.03%
+22,799
New +$2.64M
AIR icon
152
AAR Corp
AIR
$5.86B
$2.46M 0.03%
+29,729
New +$2.46M
MDLN
153
Medline Inc
MDLN
$31B
$2.44M 0.03%
+58,016
New +$2.45M
CIEN icon
154
Ciena
CIEN
$57.9B
$2.43M 0.03%
+10,400
New +$2.02M
TPL icon
155
Texas Pacific Land
TPL
$26.3B
$2.38M 0.03%
8,296
+526
+7% +$161K
BRBR icon
156
BellRing Brands
BRBR
$1.47B
$2.29M 0.03%
85,521
-186,414
-69% -$5.79M
HON icon
157
Honeywell
HON
$78.6B
$2.27M 0.03%
+11,657
New +$2.28M
PDSB icon
158
PDS Biotechnology
PDSB
$40.6M
$2.18M 0.03%
+2,834,506
New +$2.56M
ADBE icon
159
Adobe
ADBE
$103B
$2.17M 0.03%
+6,194
New +$2.11M
WKSP icon
160
Worksport
WKSP
$11M
$2.06M 0.02%
+966,008
New +$2.7M
CELH icon
161
Celsius Holdings
CELH
$7.45B
$1.81M 0.02%
+39,664
New +$2M
PRSU
162
Pursuit Attractions and Hospitality Inc
PRSU
$1.38B
$1.6M 0.02%
47,500
– –
LTH icon
163
Life Time Group Holdings
LTH
$10.1B
$1.57M 0.02%
58,882
-114,120
-66% -$2.97M
NNVC icon
164
NanoViricides
NNVC
$36.5M
$1.55M 0.02%
+1,368,000
New +$1.92M
ELAN icon
165
Elanco Animal Health
ELAN
$13.1B
$1.54M 0.02%
+68,208
New +$1.48M
COO icon
166
Cooper Companies
COO
$14.6B
$1.47M 0.02%
17,888
+12,167
+213% +$911K
RBOT
167
DELISTED
Vicarious Surgical
RBOT
$1.31M 0.02%
+605,443
New +$2.46M
SITM icon
168
SiTime
SITM
$16.3B
$1.31M 0.02%
+3,707
New +$1.16M
REED
169
Reed's Inc
REED
$10.1M
$1.3M 0.02%
+620,000
New +$1.82M
SJM icon
170
J.M. Smucker
SJM
$12.7B
$1.27M 0.02%
+12,985
New +$1.34M
PYPL icon
171
PayPal
PYPL
$49.6B
$1.22M 0.01%
20,891
-18,384
-47% -$1.19M
MGRX icon
172
Mangoceuticals
MGRX
$7.3M
$1.14M 0.01%
+1,536,000
New +$2.49M
AZO icon
173
AutoZone
AZO
$50.1B
$1.09M 0.01%
+321
New +$1.21M
NAVN
174
Navan Inc
NAVN
$7.03B
$1.08M 0.01%
+63,373
New +$1.01M
IMNN icon
175
Imunon
IMNN
$6.68M
$1.02M 0.01%
+266,886
New +$1.14M
5 6
7
8 9

Similar funds

CRC
Curi RMB Capital Chicago, Illinois $5.62B AUM 18.93% 1-Year Est. Return
RMDI
R.M. Davis Inc Portland, Maine $5.63B AUM 21.26% 1-Year Est. Return
F
Folketrygdfondet Oslo Norway, Norway $5.64B AUM 47.16% 1-Year Est. Return
EW
Evoke Wealth Los Angeles, California $5.57B AUM 23.85% 1-Year Est. Return
O
Ossiam Paris, France $5.69B AUM 30.95% 1-Year Est. Return
DSC
Donald Smith & Co New York $5.56B AUM 47.13% 1-Year Est. Return
ACM
Altimeter Capital Management Boston, Massachusetts $5.7B AUM 36.74% 1-Year Est. Return
PI
PGGM Investments Zeist, Netherlands $5.7B AUM 17.05% 1-Year Est. Return

Armistice Capital's Q4 2025 Portfolio in Review

As of Q4 2025, Armistice Capital held 510 positions worth $8.4B, up 25% from $6.74B the previous quarter. Its ten largest holdings account for 61% of the portfolio.

Armistice Capital deployed $1.33B of net new capital in Q4 2025, opening 182 new positions and adding to 113 existing holdings. Its largest new stake was Kenvue: 3,992,196 shares worth $68.9M.

By sector, the portfolio is most concentrated in Healthcare at 33% of assets, up from 32% a quarter earlier, followed by Technology and Consumer Discretionary.

On the sell side, the largest reduction was Travere Therapeutics, an estimated $96.3M trimmed.

  • Armistice Capital's largest Q4 2025 buy was Kenvue: 3,992,196 shares worth $68.9M.
  • Armistice Capital added most to Agios Pharmaceuticals in Q4 2025, an estimated $79.7M increase.
  • Armistice Capital's biggest Q4 2025 reduction was Travere Therapeutics, cutting an estimated $96.3M.
  • Armistice Capital fully exited Exact Sciences in Q4 2025, selling an estimated $56.4M.
  • Armistice Capital's ten largest holdings make up 61% of its $8.4B portfolio in Q4 2025.
  • Armistice Capital opened 182 new positions and closed 146 in Q4 2025.
  • Armistice Capital's portfolio value rose 25% quarter-over-quarter to $8.4B.

Based on Armistice Capital's 13F filing for Q4 2025, filed 17 Feb 2026.